Group One Trading’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-71
Closed -$1.25K 8031
2023
Q1
$1.25K Buy
+71
New +$1.37K ﹤0.01% 6735
2022
Q4
Sell
-2,508
Closed -$83K 7835
2022
Q3
$83K Buy
+2,508
New +$128K ﹤0.01% 4943
2022
Q2
Sell
-74
Closed -$3.86K 8286
2022
Q1
$4K Sell
74
-1,530
-95% -$95.7K ﹤0.01% 7552
2021
Q4
$116K Buy
+1,604
New +$134K ﹤0.01% 5601
2021
Q1
Sell
-1,417
Closed -$205K 7890
2020
Q4
$185K Buy
+1,417
New +$183K ﹤0.01% 4106

Other funds holding NXTC

Group One Trading's NXTC Position: Q2 2023 in Review

Group One Trading sold out of NextCure (NXTC) in Q2 2023, closing a stake of 71 shares — an estimated $1.25K sold.

Group One Trading first reported a position in NXTC in Q4 2020 and held it in 5 quarters. The position peaked at $185K in Q4 2020. 43 funds tracked by Wall St. Rank hold NXTC as of Q2 2023.

  • Group One Trading reported no remaining NextCure position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 71 NextCure shares in Q2 2023, an estimated $1.25K.
  • Group One Trading first reported a position in NextCure in Q4 2020 and held it in 5 quarters.
  • Group One Trading's NextCure position peaked at $185K in Q4 2020.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.